-
1
-
-
84920837701
-
Cancer statistics, 2015
-
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5-29. doi:10.3322/caac.21254.
-
(2015)
CA Cancer J Clin
, vol.65
, Issue.1
, pp. 5-29
-
-
Siegel, R.L.1
Miller, K.D.2
Jemal, A.3
-
2
-
-
80051700067
-
Pancreatic cancer
-
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378(9791):607-20. doi:10.1016/S0140-6736(10)62307-0.
-
(2011)
Lancet
, vol.378
, Issue.9791
, pp. 607-620
-
-
Vincent, A.1
Herman, J.2
Schulick, R.3
Hruban, R.H.4
Goggins, M.5
-
3
-
-
83355169753
-
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial
-
Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol. 2011;29(34):4548-54. doi:10.1200/JCO.2011.36.5742.
-
(2011)
J Clin Oncol
, vol.29
, Issue.34
, pp. 4548-4554
-
-
Von Hoff, D.D.1
Ramanathan, R.K.2
Borad, M.J.3
Laheru, D.A.4
Smith, L.S.5
Wood, T.E.6
-
4
-
-
79955921754
-
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
-
Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817-25. doi:10.1056/NEJMoa1011923.
-
(2011)
N Engl J Med
, vol.364
, Issue.19
, pp. 1817-1825
-
-
Conroy, T.1
Desseigne, F.2
Ychou, M.3
Bouche, O.4
Guimbaud, R.5
Becouarn, Y.6
-
5
-
-
34547763870
-
MDR1/Pglycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma
-
O’Driscoll L, Walsh N, Larkin A, Ballot J, Ooi WS, Gullo G, et al. MDR1/Pglycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma. Anticancer Res. 2007;27(4B):2115-20.
-
(2007)
Anticancer Res
, vol.27
, Issue.4
, pp. 2115-2120
-
-
O’Driscoll, L.1
Walsh, N.2
Larkin, A.3
Ballot, J.4
Ooi, W.S.5
Gullo, G.6
-
6
-
-
78449295201
-
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma
-
Marechal R, Mackey JR, Lai R, Demetter P, Peeters M, Polus M, et al. Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma. Cancer. 2010;116(22): 5200-6. doi:10.1002/cncr.25303.
-
(2010)
Cancer
, vol.116
, Issue.22
, pp. 5200-5206
-
-
Marechal, R.1
Mackey, J.R.2
Lai, R.3
Demetter, P.4
Peeters, M.5
Polus, M.6
-
7
-
-
66349114705
-
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase
-
Costantino CL, Witkiewicz AK, Kuwano Y, Cozzitorto JA, Kennedy EP, Dasgupta A, et al. The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res. 2009;69(11):4567-72. doi:10.1158/0008-5472.CAN-09-0371.
-
(2009)
Cancer Res
, vol.69
, Issue.11
, pp. 4567-4572
-
-
Costantino, C.L.1
Witkiewicz, A.K.2
Kuwano, Y.3
Cozzitorto, J.A.4
Kennedy, E.P.5
Dasgupta, A.6
-
8
-
-
77956222392
-
HuR status is a powerful marker for prognosis and response to gemcitabinebased chemotherapy for resected pancreatic ductal adenocarcinoma patients
-
discussion −6
-
Richards NG, Rittenhouse DW, Freydin B, Cozzitorto JA, Grenda D, Rui H, et al. HuR status is a powerful marker for prognosis and response to gemcitabinebased chemotherapy for resected pancreatic ductal adenocarcinoma patients. Ann Surg. 2010;252(3):499-505. doi:10.1097/SLA.0b013e3181f1fd44. discussion −6.
-
(2010)
Ann Surg
, vol.252
, Issue.3
, pp. 499-505
-
-
Richards, N.G.1
Rittenhouse, D.W.2
Freydin, B.3
Cozzitorto, J.A.4
Grenda, D.5
Rui, H.6
-
9
-
-
77953169001
-
MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity
-
Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 2010;70(11):4528-38. doi:10.1158/0008-5472.CAN-09-4467.
-
(2010)
Cancer Res
, vol.70
, Issue.11
, pp. 4528-4538
-
-
Giovannetti, E.1
Funel, N.2
Peters, G.J.3
Del Chiaro, M.4
Erozenci, L.A.5
Vasile, E.6
-
10
-
-
79959652668
-
Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer—a review
-
Dhayat S, Mardin WA, Mees ST, Haier J. Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer—a review. Int J Cancer. 2011;129(5):1031-41. doi:10.1002/ijc.26078.
-
(2011)
Int J Cancer
, vol.129
, Issue.5
, pp. 1031-1041
-
-
Dhayat, S.1
Mardin, W.A.2
Mees, S.T.3
Haier, J.4
-
11
-
-
84955608899
-
MicroRNA profiling implies new markers of gemcitabine chemoresistance in mutant p53 pancreatic ductal adenocarcinoma
-
Dhayat SA, Mardin WA, Seggewiß J, Ströse AJ, Matuszcak C, Hummel R, et al. MicroRNA profiling implies new markers of gemcitabine chemoresistance in mutant p53 pancreatic ductal adenocarcinoma. PLoS One. 2015;10(11):e0143755. doi:10.1371/journal.pone.0143755.
-
(2015)
Plos One
, vol.10
, Issue.11
-
-
Dhayat, S.A.1
Mardin, W.A.2
Seggewiß, J.3
Ströse, A.J.4
Matuszcak, C.5
Hummel, R.6
-
12
-
-
0343618387
-
The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation
-
Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Kloppel G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000;191(2):154-61. doi:10.1002/(SICI)1096-9896(200006)191:2<154::AIDPATH603> 3.0.CO;2-C.
-
(2000)
J Pathol
, vol.191
, Issue.2
, pp. 154-161
-
-
Luttges, J.1
Schemm, S.2
Vogel, I.3
Hedderich, J.4
Kremer, B.5
Kloppel, G.6
-
13
-
-
0037208652
-
Prognostic factors following curative resection for pancreatic adenocarcinoma: A population-based, linked database analysis of 396 patients
-
Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237(1):74-85. doi:10.1097/01.SLA.0000041266.10047.38.
-
(2003)
Ann Surg
, vol.237
, Issue.1
, pp. 74-85
-
-
Lim, J.E.1
Chien, M.W.2
Earle, C.C.3
-
14
-
-
77956296766
-
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer
-
Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, Kim YT, et al. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One. 2010;5(5):e10630. doi:10.1371/journal.pone.0010630.
-
(2010)
Plos One
, vol.5
, Issue.5
-
-
Hwang, J.H.1
Voortman, J.2
Giovannetti, E.3
Steinberg, S.M.4
Leon, L.G.5
Kim, Y.T.6
-
15
-
-
70350362953
-
Hyaluronan-CD44 interaction with protein kinase C(Epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells
-
Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem. 2009;284(39):26533-46. doi:10.1074/jbc.M109.027466.
-
(2009)
J Biol Chem
, vol.284
, Issue.39
, pp. 26533-26546
-
-
Bourguignon, L.Y.1
Spevak, C.C.2
Wong, G.3
Xia, W.4
Gilad, E.5
-
16
-
-
78650491562
-
Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics
-
Allen KE, Weiss GJ. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther. 2010;9(12):3126-36. doi:10.1158/1535-7163.MCT-10-0397.
-
(2010)
Mol Cancer Ther
, vol.9
, Issue.12
, pp. 3126-3136
-
-
Allen, K.E.1
Weiss, G.J.2
-
17
-
-
84901474141
-
MiRNAs for the detection of multidrug resistance: Overview and perspectives
-
Gisel A, Valvano M, El Idrissi IG, Nardulli P, Azzariti A, Carrieri A, et al. miRNAs for the detection of multidrug resistance: overview and perspectives. Molecules. 2014;19(5):5611-23. doi:10.3390/molecules19055611.
-
(2014)
Molecules
, vol.19
, Issue.5
, pp. 5611-5623
-
-
Gisel, A.1
Valvano, M.2
El Idrissi, I.G.3
Nardulli, P.4
Azzariti, A.5
Carrieri, A.6
-
18
-
-
0023889448
-
Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16
-
Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res. 1988;48(7):1926-9.
-
(1988)
Cancer Res
, vol.48
, Issue.7
, pp. 1926-1929
-
-
Sugawara, I.1
Kataoka, I.2
Morishita, Y.3
Hamada, H.4
Tsuruo, T.5
Itoyama, S.6
-
19
-
-
0025011004
-
Clinical significance of multiple drug resistance in human cancers
-
Benard J, Bourhis J, Riou G. Clinical significance of multiple drug resistance in human cancers. Anticancer Res. 1990;10(5A):1297-302.
-
(1990)
Anticancer Res
, vol.10
, Issue.5
, pp. 1297-1302
-
-
Benard, J.1
Bourhis, J.2
Riou, G.3
-
20
-
-
84855270724
-
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer
-
Chen M, Xue X, Wang F, An Y, Tang D, Xu Y, et al. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. Oncol Rep. 2012;27(1):265-9. doi:10.3892/or.2011.1475.
-
(2012)
Oncol Rep
, vol.27
, Issue.1
, pp. 265-269
-
-
Chen, M.1
Xue, X.2
Wang, F.3
An, Y.4
Tang, D.5
Xu, Y.6
-
21
-
-
0029665330
-
Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: Relevance to indicator of better prognosis
-
Suwa H, Ohshio G, Arao S, Imamura T, Yamaki K, Manabe T, et al. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis. Jpn J Cancer Res. 1996;87(6):641-9.
-
(1996)
Jpn J Cancer Res
, vol.87
, Issue.6
, pp. 641-649
-
-
Suwa, H.1
Ohshio, G.2
Arao, S.3
Imamura, T.4
Yamaki, K.5
Manabe, T.6
-
22
-
-
66849124564
-
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
-
Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 2009;8(5):1067-74. doi:10.1158/1535-7163.MCT-08-0592.
-
(2009)
Mol Cancer Ther
, vol.8
, Issue.5
, pp. 1067-1074
-
-
Moriyama, T.1
Ohuchida, K.2
Mizumoto, K.3
Yu, J.4
Sato, N.5
Nabae, T.6
-
23
-
-
75549091145
-
Pancreatic adenocarcinoma: New strategies for success
-
O’Reilly EM. Pancreatic adenocarcinoma: new strategies for success. Gastrointest Cancer Res. 2009;3(2 Suppl):S11-5.
-
(2009)
Gastrointest Cancer Res
, vol.3
, Issue.2
, pp. S11-S15
-
-
O’Reilly, E.M.1
-
24
-
-
77952111316
-
Circulating miR-210 as a novel hypoxia marker in pancreatic cancer
-
Ho AS, Huang X, Cao H, Christman-Skieller C, Bennewith K, Le QT, et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol. 2010;3(2):109-13.
-
(2010)
Transl Oncol
, vol.3
, Issue.2
, pp. 109-113
-
-
Ho, A.S.1
Huang, X.2
Cao, H.3
Christman-Skieller, C.4
Bennewith, K.5
Le, Q.T.6
-
25
-
-
34247862190
-
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
-
Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Jama. 2007;297(17):1901-8. doi:10.1001/jama.297.17.1901.
-
(2007)
Jama
, vol.297
, Issue.17
, pp. 1901-1908
-
-
Bloomston, M.1
Frankel, W.L.2
Petrocca, F.3
Volinia, S.4
Alder, H.5
Hagan, J.P.6
-
26
-
-
79951529658
-
MiR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes
-
Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate. 2011;71(5):538-49. doi:10.1002/pros.21270.
-
(2011)
Prostate
, vol.71
, Issue.5
, pp. 538-549
-
-
Shi, X.B.1
Xue, L.2
Ma, A.H.3
Tepper, C.G.4
Kung, H.J.5
White, R.W.6
-
27
-
-
84888881174
-
MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
-
Wu N, Lin X, Zhao X, Zheng L, Xiao L, Liu J, et al. MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways. Br J Cancer. 2013;109(11):2853-63. doi:10.1038/bjc.2013.672.
-
(2013)
Br J Cancer
, vol.109
, Issue.11
, pp. 2853-2863
-
-
Wu, N.1
Lin, X.2
Zhao, X.3
Zheng, L.4
Xiao, L.5
Liu, J.6
-
28
-
-
77954378366
-
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression
-
Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem. 2010;285(28):21496-507. doi:10.1074/jbc.M109.083337.
-
(2010)
J Biol Chem
, vol.285
, Issue.28
, pp. 21496-21507
-
-
Zhou, M.1
Liu, Z.2
Zhao, Y.3
Ding, Y.4
Liu, H.5
Xi, Y.6
-
29
-
-
84898887673
-
MiR-99a/100 ~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFbeta and Wnt signaling
-
Emmrich S, Rasche M, Schoning J, Reimer C, Keihani S, Maroz A, et al. miR-99a/100 ~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFbeta and Wnt signaling. Genes Dev. 2014;28(8):858-74. doi:10.1101/gad.233791.113.
-
(2014)
Genes Dev
, vol.28
, Issue.8
, pp. 858-874
-
-
Emmrich, S.1
Rasche, M.2
Schoning, J.3
Reimer, C.4
Keihani, S.5
Maroz, A.6
-
30
-
-
78650716349
-
Differential miRNA expression profiles in bladder urothelial carcinomas
-
Song T, Xia W, Shao N, Zhang X, Wang C, Wu Y, et al. Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev. 2010;11(4):905-11.
-
(2010)
Asian Pac J Cancer Prev
, vol.11
, Issue.4
, pp. 905-911
-
-
Song, T.1
Xia, W.2
Shao, N.3
Zhang, X.4
Wang, C.5
Wu, Y.6
-
31
-
-
50849137458
-
MicroRNA expression profiles in serous ovarian carcinoma
-
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690-5. doi:10.1158/1078-0432.CCR-07-1731.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.9
, pp. 2690-2695
-
-
Nam, E.J.1
Yoon, H.2
Kim, S.W.3
Kim, H.4
Kim, Y.T.5
Kim, J.H.6
-
33
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method
-
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 2001;25(4):402-8. doi:10.1006/meth.2001.1262.
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
34
-
-
0035061867
-
Tissue microarray technology for high-throughput molecular profiling of cancer
-
Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001;10(7):657-62.
-
(2001)
Hum Mol Genet
, vol.10
, Issue.7
, pp. 657-662
-
-
Kallioniemi, O.P.1
Wagner, U.2
Kononen, J.3
Sauter, G.4
-
35
-
-
84879824031
-
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
-
Nath S, Daneshvar K, Roy LD, Grover P, Kidiyoor A, Mosley L, et al. MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. Oncogenesis. 2013;2, e51. doi:10.1038/oncsis.2013.16.
-
(2013)
Oncogenesis
, vol.2
-
-
Nath, S.1
Daneshvar, K.2
Roy, L.D.3
Grover, P.4
Kidiyoor, A.5
Mosley, L.6
-
36
-
-
82155163849
-
The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2
-
Hamada S, Satoh K, Hirota M, Kanno A, Umino J, Ito H, et al. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. J Cell Physiol. 2012;227(2):729-38. doi:10.1002/jcp.22781.
-
(2012)
J Cell Physiol
, vol.227
, Issue.2
, pp. 729-738
-
-
Hamada, S.1
Satoh, K.2
Hirota, M.3
Kanno, A.4
Umino, J.5
Ito, H.6
-
37
-
-
84925226151
-
VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis
-
Georgiadou D, Sergentanis TN, Sakellariou S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, et al. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. Eur J Surg Oncol. 2014;40(10):1331-7. doi:10.1016/j.ejso.2014.01.004.
-
(2014)
Eur J Surg Oncol
, vol.40
, Issue.10
, pp. 1331-1337
-
-
Georgiadou, D.1
Sergentanis, T.N.2
Sakellariou, S.3
Filippakis, G.M.4
Zagouri, F.5
Vlachodimitropoulos, D.6
-
38
-
-
0019492861
-
A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies
-
Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981;75(5):734-8.
-
(1981)
Am J Clin Pathol
, vol.75
, Issue.5
, pp. 734-738
-
-
Hsu, S.M.1
Raine, L.2
Fanger, H.3
-
39
-
-
0035987866
-
Partitioning and peeling for constructing prognostic groups
-
LeBlanc M, Jacobson J, Crowley J. Partitioning and peeling for constructing prognostic groups. Stat Methods Med Res. 2002;11(3):247-74.
-
(2002)
Stat Methods Med Res
, vol.11
, Issue.3
, pp. 247-274
-
-
Leblanc, M.1
Jacobson, J.2
Crowley, J.3
-
40
-
-
45449087921
-
QBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
-
Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19. doi:10.1186/gb-2007-8-2-r19.
-
(2007)
Genome Biol
, vol.8
, Issue.2
-
-
Hellemans, J.1
Mortier, G.2
De Paepe, A.3
Speleman, F.4
Vandesompele, J.5
|